Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHESTER JONES

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care

NPI
1124578455
CMS profile
10546114
Location
GRAND PRAIRIE, TX

General Payments · PY2021–2022

$1,263.94

  • Reported across 23 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$702.77

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $702.77 14

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $125.00 1
Teva Pharmaceuticals USA, Inc. $110.94 1
Ultragenyx Pharmaceutical Inc. $106.58 1
Stemline Therapeutics Inc. $83.07 1
Amarin Pharma Inc. $75.50 4
Medtronic, Inc. $71.43 1
ABBVIE INC. $61.09 1
Amgen Inc. $20.52 1
Abbott Laboratories $17.51 1
Genentech USA, Inc. $15.87 1
Novo Nordisk AS $15.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $561.17 9
PY2022 $702.77 14

Payment records · PY2022 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2022 2021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $17.51 02/01/2022 Food and Beverage Undisputed 01/23/2026 920077059 CMS
ABBVIE INC. $61.09 05/10/2022 Food and Beverage Undisputed 01/23/2026 892072597 CMS
Amarin Pharma Inc. $21.20 02/21/2022 Food and Beverage Undisputed 01/23/2026 913965971 CMS
Amarin Pharma Inc. $20.17 04/07/2022 Food and Beverage Undisputed 01/23/2026 913972291 CMS
Amarin Pharma Inc. $18.33 05/13/2022 Food and Beverage Undisputed 01/23/2026 913965973 CMS
Amarin Pharma Inc. $15.80 06/29/2022 Food and Beverage Undisputed 01/23/2026 913982851 CMS
Amgen Inc. $20.52 05/31/2022 Food and Beverage Undisputed 01/23/2026 940035737 CMS
AstraZeneca Pharmaceuticals LP $125.00 04/05/2022 Food and Beverage Undisputed 01/23/2026 915559203 CMS
Genentech USA, Inc. $15.87 02/07/2022 Food and Beverage Undisputed 01/23/2026 950683317 CMS
Medtronic, Inc. $71.43 11/09/2022 Food and Beverage Undisputed 01/23/2026 930463163 CMS
Novo Nordisk Inc $15.26 03/15/2022 Food and Beverage Undisputed 01/23/2026 899144337 CMS
Stemline Therapeutics Inc. $83.07 08/09/2022 Food and Beverage Undisputed 01/23/2026 965327571 CMS
Teva Pharmaceuticals USA, Inc. $110.94 06/14/2022 Food and Beverage Undisputed 01/23/2026 954713481 CMS
Ultragenyx Pharmaceutical Inc. $106.58 12/13/2022 Food and Beverage Undisputed 01/23/2026 963749769 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022
Source files
Dataset page · Bulk file · PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.